newsfilter
← Latest News
Business Wire·

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

Total global revenues of $1.7 billion for the second quarter, an increase of 30% from the prior year BRUKINSA (zanubrutinib) global revenues of $1.2 billion for the second quarter, an increase of 31% from the